Although detecting any of SARS-CoV-2 RNA, antigens and antibodies in saliva could determine the infection status, most of saliva-based point-of-care biosensors aim to SARS-CoV-2 antigens (S protein, N protein, 3CL protease, and etc.)for rapid antigen tests. The gene discussed is PROS1; the disease is infection.